Drawing for EPVELCY

USPTO serial 87146836

EPVELCY

Reviewed by CopyMark Law Group

Reg. 6088019Status 700Renewal
Filing date
Status date
Registration date
Jun 30, 2020
Examiner
BAL, KAMAL SINGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EPVELCY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shelley Lai

Shelley Lai Gilead Sciences, Inc.333 Lakeside DriveFoster City, CA 94404United States

Goods and services

ClassDescriptionStatusFirst use
005Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 22, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 22, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 30, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 11, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 11, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 11, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 11, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 30, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 26, 2020DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
May 15, 2020IUCNNOTICE OF ALLOWANCE CANCELLED—
May 15, 2020D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Dec 3, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2019EX5GSOU EXTENSION 5 GRANTED—
Dec 2, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 25, 2019EXT5SOU EXTENSION 5 FILED—
Nov 25, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 11, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 9, 2019EX4GSOU EXTENSION 4 GRANTED—
May 9, 2019EXT4SOU EXTENSION 4 FILED—
May 9, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 13, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 9, 2018EX3GSOU EXTENSION 3 GRANTED—
Nov 9, 2018EXT3SOU EXTENSION 3 FILED—
Nov 9, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2018EX2GSOU EXTENSION 2 GRANTED—
May 15, 2018EXT2SOU EXTENSION 2 FILED—
May 15, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 11, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 9, 2017EX1GSOU EXTENSION 1 GRANTED—
Nov 9, 2017EXT1SOU EXTENSION 1 FILED—
Nov 9, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 23, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 19, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 6, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2017ALIEASSIGNED TO LIE—
Mar 23, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2016DOCKASSIGNED TO EXAMINER—
Aug 26, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance